2
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Single Dose of Pindolol in Normotensive Pregnancy: The Lack of Changes in Hemodynamics in Spite of Effective Beta-Receptor Binding

, , , &
Pages 173-181 | Published online: 07 Jul 2009

References

  • Gugler R, Herald W, Dengler H J. Pharmacokinetics of pindolol in man. Eur J Clin Pharmacol. 1974; 7: 17–24
  • McDevitt D G, Shand D G. Plasma concentrations and the time-course of beta-blockade due to propranolol. Clin Pharmacol Ther. 1975; 18: 708–13
  • Ishizaki T. Likely explanation for longer duration of pharmacological (antianginal) effects of propranolol in relation to its short half-life. Res Commun Chem Pathol Pharmacol. 1980; 27: 223–39
  • Wellstein A, Palm D, Pitschner H F, Belz G G. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. Eur J Clin Pharmacol. 1985; 29: 131–47
  • Kurjak A, Alfirevic Z, Miljan M. Conventional and color Doppler in the assessment of fetal and maternal circulation. Ultrasound Med Biol. 1988; 14: 337–54
  • Kaila T. A sensitive radioligand binding assay for timolol in plasma. J Pharm Sci. 1991; 80: 296–9
  • Lubbe W F. Hypertension in pregnancy: Whom and how to treat. Br J Clin Pharmacol. 1987; 24(Suppl 1)158
  • Fiddler G I. Propranolol and pregnancy. Lancet 1974; 2: 722–3
  • Kjellmer I, Dagbjartsson A, Hrbek A, Karlsson K, Rosen K G. Maternal beta-adrenoreceptor blockade reduces fetal tolerance to asphyxia. Acta Obstet Gynecol Scand Suppl. 1984, Suppl 118: 75–80
  • Butters L, Kennedy S, Rubin P C. Atenolol in essential hypertension during pregnancy. BMJ 1990; 301: 587–9
  • Dubois D, Petitcolas J, Temperville B, Klepper A. Treatment of hypertension in pregnancy with beta-adrenoreceptor antagonists. Br J Clin Pharmacol. 1982; 13: 375–8
  • Sukerman-Voldman E. Pindolol therapy in pregnant hypertensive patients. Br J Clin Pharmacol. 1982; 13: 379
  • Montan S, Ingemarsson I, Marsal K, Sjoberg N-O. Randomized controlled trial of atenolol and pindolol in human pregnancy: Effects on fetal haemodynamics. BMJ 1992; 304: 946–9
  • Hanson L. Beta-adrenergic blockade in essential hypertension. Acta Med Scand Suppl. 1973, Suppl 550: 1
  • Atterhög J H, Duner H, Pernow B. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension. Am J Med. 1976; 60: 872
  • Lunell N O, Nylund L, Lewander R, Sarby B, Wager J. Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adrenoreceptor blocker, pindolol. Gynecol Obstet Invest. 1984; 18: 269–74
  • Tuimala R, Hartikainen-Sorri A-L. Randomized comparison of atenolol and pindolol for treatment of hypertension in pregnancy. Curr Ther Res. 1988; 44: 579–84
  • Ingemarsson I, Adaikan P G, Arulkumaran S, Kottegoda S R. Effect of a beta-adrenoreceptor antagonist, pindolol, on human uterine smooth muscle. Gynecol Obstet Invest. 1987; 24: 185–9
  • Egarter C, Meisner W, Kroboth W K, Grunberger W. Effect of beta-adrenoreceptor blockers on uterine contractility in a puerperal model. Acta Obstet Gynecol Scand. 1989; 68: 359–62
  • Juma F D. Pharmacokinetics of pindolol in Kenyan Africans. Eur J Clin Pharmacol. 1983; 25: 425–6
  • Gretzer I, Alvan G, Duner H, Garle M, Sjöqvist F. Beta-blocking effect and pharmacokinetics of pindolol in young and elderly hypertensive patients. Eur J Clin Pharmacol. 1986; 31: 415–9
  • Aellig W H. Clinical pharmacology of pindolol. Am Heart J. 1982; 104: 346–56

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.